Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies (Q40131537)
Jump to navigation
Jump to search
scientific article published on 4 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies |
scientific article published on 4 July 2017 |
Statements
1 reference
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies (English)
1 reference
1 reference
1 reference
Gerold Meinhardt
1 reference
Keiko Nakajima
1 reference
Yoriko De Sanctis
1 reference
4 July 2017
1 reference
1 reference
Identifiers
1 reference